[시장보고서]내시경 검사 분야 AI 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 구성요소별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

내시경 검사 분야 AI 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 구성요소별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

AI In Endoscopy Market Size, Share & Trends Analysis Report By Type (CADe, CADx ), By Component, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1908175

리서치사 : Grand View Research

발행일 : 2025년 12월

페이지 정보 : 영문 100 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,698,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,160,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,084,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

내시경 검사 분야 AI 시장 개요

세계의 내시경 검사 분야 AI 시장 규모는 2024년에 29억 3,000만 달러로 평가되었으며, 2033년에 195억 3,000만 달러에 달할 것으로 예측됩니다.

2026-2033년에는 CAGR 26.83%로 성장할 것으로 예상됩니다. 대장암과 염증성 장질환을 포함한 소화기 질환의 전 세계 부담 증가, 최소침습 내시경 검사로의 큰 전환은 시장 성장에 기여하는 중요한 요인입니다.

또한 인공지능(특히 머신러닝과 컴퓨터 비전)의 급속한 발전이 AI 내시경 검사 시장의 혁신을 주도하고 있습니다. 대장암 및 염증성 장질환을 포함한 소화기 질환의 전 세계 부담 증가는 AI 내시경 시장의 주요 촉진요인입니다. 예를 들어, 미국암협회(American Cancer Society)의 추산에 따르면, 2024년 미국에서 약 1만 3,920건의 새로운 대장암이 진단되고 2,060명이 대장암으로 사망할 것으로 예상됩니다. 전 세계적으로 대장암 발병률이 증가함에 따라 효과적인 진단 및 치료법에 대한 요구가 증가하고 있습니다. 캡슐 내시경 검사는 다양한 형태의 암을 정확하게 진단, 병기 및 치료할 수 있는 최소침습적 치료 옵션을 제공하는 데 중요한 역할을 하고 있습니다.

마찬가지로, 세계 암 연구 기금에 따르면, 2022년에는 전 세계적으로 약 193만 건의 대장암이 보고되어 가장 널리 퍼져 있는 악성 종양 중 하나가 될 것으로 예상됩니다. 세계보건기구는 유럽, 호주, 뉴질랜드 등의 지역에서 주로 생활습관, 식습관, 고령화 등의 요인으로 인해 가장 높은 발병률을 보이고 있다고 강조하고 있습니다.

지역별 시장 점유율 분석(2025년과 2033년)
지역별 시장 대시보드
시장 규모와 예측 동향 분석, 2021-2033년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 구도

기업/경쟁 분류
전략 매핑
2025년의 기업 시장 상황 분석
기업 개요/리스트
- FUJIFILM Corporation
- Olympus Corporation
- Medtronic
- MAGENTIQ EYE
- PENTAX Medical(HOYA Group)
- JINSHAN Science & Technology(Group) Co., Ltd.
- BioCam
- Endovision
- EndoSoft
- AnX Robotica
- Provation Software, Inc.
- ODIN VISION(ODIN MEDICAL LTD)

KSM

영문 목차

영문목차

AI In Endoscopy Market Summary

The global AI in endoscopy market size was valued at USD 2.93 billion in 2024 and is projected to reach USD 19.53 billion by 2033, growing at a CAGR of 26.83% from 2026 to 2033. increasing global burden of gastrointestinal diseases, including colorectal cancer and inflammatory bowel disease and a significant shift toward minimally invasive endoscopic procedures are significant factors contributing to market growth.

Additionally, rapid advancements in artificial intelligence, particularly in machine learning and computer vision, are driving innovation in the AI endoscopy market. The increasing global burden of gastrointestinal diseases, including colorectal cancer and inflammatory bowel disease, is a primary driver of AI in endoscopy market. For instance, according to the American Cancer Society estimates, in 2024, around 13,920 new small intestine cancer cases were diagnosed in the U.S., and 2,060 individuals died due to small intestine cancer. As the prevalence of small intestine cancer rises globally, there is a growing need for effective diagnostic and treatment procedures. Capsule endoscopy plays a crucial role in offering minimally invasive options to accurately diagnose, stage, and treat various forms of cancer.

Similarly, according to the World Cancer Research Fund, approximately 1.93 million new cases of colorectal cancer were reported globally in 2022, making it one of the most prevalent malignancies. The World Health Organization further emphasizes that regions such as Europe, Australia, and New Zealand exhibit the highest incidence rates, largely due to lifestyle factors, diet, and aging populations.

Global AI In Endoscopy Market Report Segmentation

This report forecasts, revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in endoscopy market report based on component, type, application, end use, and region.

Type Outlook (Revenue, USD Million, 2021 - 2033)
CADe (Computer-Aided Detection)
CADx (Computer-Aided Diagnosis)
Component Outlook (Revenue, USD Million, 2021 - 2033)
AI-enabled devices
AI Software and Platforms
Services
Application Outlook (Revenue, USD Million, 2021 - 2033)
Gastrointestinal Endoscopy
Bronchoscopy
Urological Endoscopy
Capsule Endoscopy
Gynecological Endoscopy
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers/Specialty clinics
Diagnostic imaging centers
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Type Segment
- 1.2.2. Component Segment
- 1.2.3. Application Segment
- 1.2.4. End Use
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. AI in Endoscopy Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.2.3. Market opportunity analysis
- 3.2.4. Market challenges analysis
3.3. AI in Endoscopy Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape
  - 3.3.2.4. Environmental Landscape
  - 3.3.2.5. Legal Landscape
  - 3.3.2.6. Social Landscape

Chapter 4. AI in Endoscopy Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global AI in Endoscopy Market Type Movement Analysis
4.3. Global AI in Endoscopy Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. CADe (Computer-Aided Detection)
- 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. CADx (Computer-Aided Diagnosis)
- 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Endoscopy Market: Component Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global AI in Endoscopy Market Component Movement Analysis
5.3. Global AI in Endoscopy Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
5.4. AI-enabled Devices
- 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. AI Software & Platform
- 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Services
- 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Endoscopy Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global AI in Endoscopy Market Application Movement Analysis
6.3. Global AI in Endoscopy Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Gastrointestinal Endoscopy
- 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Bronchoscopy
- 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Urological Endoscopy
- 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Capsule Endoscopy
- 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.8. Gynecological Endoscopy
- 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.9. Others
- 6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Endoscopy Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global AI in Endoscopy Market End Use Movement Analysis
7.3. Global AI in Endoscopy Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals
- 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Ambulatory Surgical Centers/Specialty clinics
- 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Diagnostic Imaging Centers
- 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Others
- 7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI in Endoscopy Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
- 8.4.1. U.S.
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Regulatory framework
  - 8.4.1.3. Competitive scenario
  - 8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.4.2. Canada
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Regulatory framework
  - 8.4.2.3. Competitive scenario
  - 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.4.3. Mexico
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Regulatory framework
  - 8.4.3.3. Competitive scenario
  - 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5.2. Germany
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5.3. France
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5.4. Italy
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Regulatory framework
  - 8.5.4.3. Competitive scenario
  - 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5.5. Spain
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Regulatory framework
  - 8.5.5.3. Competitive scenario
  - 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5.6. Norway
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Regulatory framework
  - 8.5.6.3. Competitive scenario
  - 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5.7. Sweden
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Regulatory framework
  - 8.5.7.3. Competitive scenario
  - 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Regulatory framework
  - 8.5.8.3. Competitive scenario
  - 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.6.2. China
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.6.3. India
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory framework
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.6.4. Australia
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory framework
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory framework
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.6.6. Thailand
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory framework
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.7.2. Argentina
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Regulatory framework
  - 8.8.1.3. Competitive scenario
  - 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory framework
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.8.3. UAE
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Regulatory framework
  - 8.8.3.3. Competitive scenario
  - 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.8.4. Kuwait
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Regulatory framework
  - 8.8.4.3. Competitive scenario
  - 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
- 9.4.1. FUJIFILM Corporation
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Olympus Corporation
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Medtronic
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. MAGENTIQ EYE
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. PENTAX Medical (HOYA Group)
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. JINSHAN Science & Technology (Group) Co., Ltd.
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. BioCam
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Endovision
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. EndoSoft
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. AnX Robotica
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product benchmarking
  - 9.4.10.4. Strategic initiatives
- 9.4.11. Provation Software, Inc.
  - 9.4.11.1. Company overview
  - 9.4.11.2. Financial performance
  - 9.4.11.3. Product benchmarking
  - 9.4.11.4. Strategic initiatives
- 9.4.12. ODIN VISION (ODIN MEDICAL LTD)
  - 9.4.12.1. Company overview
  - 9.4.12.2. Financial performance
  - 9.4.12.3. Product benchmarking
  - 9.4.12.4. Strategic initiatives

한글목차

내시경 검사 분야 AI 시장 개요

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 내시경 검사 분야 AI 시장 변수, 동향과 범위

제4장 내시경 검사 분야 AI 시장 : 유형별, 추정·동향 분석

제5장 내시경 검사 분야 AI 시장 : 구성요소별, 추정·동향 분석

제6장 내시경 검사 분야 AI 시장 : 용도별, 추정·동향 분석

제7장 내시경 검사 시장의 AI : 최종 용도별, 추정·동향 분석

제8장 내시경 검사 분야 AI 시장 : 지역별, 추정·동향 분석